Panagora Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,698
Closed -$250K 1461
2022
Q3
$250K Buy
7,698
+417
+6% +$17.2K ﹤0.01% 1323
2022
Q2
$287K Hold
7,281
﹤0.01% 1318
2022
Q1
$509K Buy
7,281
+323
+5% +$23.6K ﹤0.01% 1202
2021
Q4
$542K Hold
6,958
﹤0.01% 1186
2021
Q3
$664K Sell
6,958
-948
-12% -$100K ﹤0.01% 1170
2021
Q2
$983K Buy
7,906
+3,492
+79% +$417K 0.01% 992
2021
Q1
$582K Buy
4,414
+2,145
+95% +$294K ﹤0.01% 1263
2020
Q4
$301K Buy
2,269
+1,321
+139% +$160K ﹤0.01% 1421
2020
Q3
$97K Buy
948
+493
+108% +$42.6K ﹤0.01% 1804
2020
Q2
$40K Buy
455
+189
+71% +$15.1K ﹤0.01% 2031
2020
Q1
$15K Buy
266
+258
+3,225% +$20.9K ﹤0.01% 2087
2019
Q4
$1K Buy
+8
New +$703 ﹤0.01% 2398
2017
Q1
Sell
-23,727
Closed -$317K 2398
2016
Q4
$317K Buy
+23,727
New +$383K ﹤0.01% 1602
2016
Q1
Sell
-3,514
Closed -$32K 2306
2015
Q4
$32K Buy
+3,514
New +$32.7K ﹤0.01% 2082

Other funds holding EXAS

Panagora Asset Management's EXAS Position: Q4 2022 in Review

Panagora Asset Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 7,698 shares — an estimated $250K sold.

Panagora Asset Management first reported a position in EXAS in Q4 2015 and held it in 14 quarters. The position peaked at $983K in Q2 2021. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Panagora Asset Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Panagora Asset Management sold 7,698 Exact Sciences shares in Q4 2022, an estimated $250K.
  • Panagora Asset Management first reported a position in Exact Sciences in Q4 2015 and held it in 14 quarters.
  • Panagora Asset Management's Exact Sciences position peaked at $983K in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Panagora Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.